The utility of urine-circulating miRNAs for detection of prostate cancer

被引:0
作者
Kristina Stuopelyte
Kristina Daniunaite
Arnas Bakavicius
Juozas R Lazutka
Feliksas Jankevicius
Sonata Jarmalaite
机构
[1] Faculty of Natural Sciences,Division of Human Genome Research Centre
[2] Vilnius University,undefined
[3] Urology Centre,undefined
[4] Vilnius University,undefined
[5] National Cancer Institute,undefined
来源
British Journal of Cancer | 2016年 / 115卷
关键词
prostate cancer; miRNA; urine; miR-148a; miR-375;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:707 / 715
页数:8
相关论文
共 346 条
[1]  
Ambs S(2008)Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer Cancer Res 68 6162-6170
[2]  
Prueitt RL(2006)Identification by real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues Mol Cancer 5 29-616
[3]  
Yi M(2011)Circulating miRNAs are correlated with tumor progression in prostate cancer Int J Cancer 128 608-3052
[4]  
Hudson RS(2010)Prostate cancer incidence and mortality trends in 37 European countries: an overview Eur J Cancer 46 3040-774
[5]  
Howe TM(2012)Changes in circulating microRNA levels associated with prostate cancer Br J Cancer 106 768-319
[6]  
Petrocca F(2015)Formononetin promotes proliferation that involves a feedback loop of microRNA-375 and estrogen receptor alpha in estrogen receptor-positive cells Mol Carcinog 55 312-1334
[7]  
Wallace TA(2013)Circulating microRNA profiling identifies a subset of metastatic prostate cancer patients with evidence of cancer-associated hypoxia PLoS One 8 e69239-477
[8]  
Liu CG(2014)miR-34a is an intracellular and exosomal predictive biomarker for response to docetaxel with clinical relevance to prostate cancer progression Prostate 74 1320-1855
[9]  
Volinia S(2011)MicroRNAs in body fluids—the mix of hormones and biomarkers Nat Rev Clin Oncol 8 467-896
[10]  
Calin GA(2014)Prognostic value of RASSF1 promoter methylation in prostate cancer J Urol 192 1849-23